Mark Keegan

1.5k total citations
11 papers, 1.1k citations indexed

About

Mark Keegan is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Mark Keegan has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 2 papers in Molecular Biology. Recurrent topics in Mark Keegan's work include Peripheral Neuropathies and Disorders (3 papers), Multiple Sclerosis Research Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). Mark Keegan is often cited by papers focused on Peripheral Neuropathies and Disorders (3 papers), Multiple Sclerosis Research Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). Mark Keegan collaborates with scholars based in United States, France and Türkiye. Mark Keegan's co-authors include Moses Rodriguez, Brian G. Weinshenker, Robyn L. McClelland, C. H. Darby, Alvaro A. Pineda, Claudia F. Lucchinetti, Hillel Panitch, Joseph E. Parisi, Hans Lassmann and Andreas Bitsch and has published in prestigious journals such as The Lancet, The Journal of Immunology and Gastroenterology.

In The Last Decade

Mark Keegan

9 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Keegan United States	7	623	523	234	169	141	11	1.1k
Becky Parks United States	17	680 1.1×	348 0.7×	319 1.4×	167 1.0×	171 1.2×	31	1.2k
Amy Pace United States	8	1.0k 1.6×	555 1.1×	252 1.1×	282 1.7×	109 0.8×	15	1.2k
Julius Lukas Austria	16	745 1.2×	253 0.5×	92 0.4×	22 0.1×	46 0.3×	39	975
Amy Kunchok United States	16	517 0.8×	807 1.5×	84 0.4×	227 1.3×	137 1.0×	47	1.0k
Rifaat Bashir United States	15	424 0.7×	408 0.8×	87 0.4×	45 0.3×	159 1.1×	25	1.0k
A Helwig Germany	9	233 0.4×	54 0.1×	260 1.1×	80 0.5×	79 0.6×	21	698
T Sano Japan	22	159 0.3×	150 0.3×	106 0.5×	216 1.3×	224 1.6×	39	1.3k
Lorenz Thurner Germany	16	233 0.4×	235 0.4×	126 0.5×	82 0.5×	157 1.1×	63	730
Maria Rosaria Tola Italy	19	326 0.5×	266 0.5×	326 1.4×	93 0.6×	199 1.4×	29	975
Hiroaki Hiraga Japan	21	188 0.3×	132 0.3×	160 0.7×	312 1.8×	409 2.9×	62	1.5k

Countries citing papers authored by Mark Keegan

Since Specialization

Citations

This map shows the geographic impact of Mark Keegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Keegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Keegan more than expected).

Fields of papers citing papers by Mark Keegan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Keegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Keegan. The network helps show where Mark Keegan may publish in the future.

Co-authorship network of co-authors of Mark Keegan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Keegan. A scholar is included among the top collaborators of Mark Keegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Keegan. Mark Keegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Keegan, Mark, Yong Guo, Darin T. Okuda, et al.. (2016). Radiologically Isolated Syndrome: Pathologically Defined as Demyelinating Disease (P1.391). Neurology. 86(16_supplement). 2 indexed citations

Sıva, Aksel, Melih Tütüncü, Orhun H. Kantarci, et al.. (2015). Are individuals with Radiologically Isolated Syndrome have a different clinical outcome once they convert to Clinically Isolated Syndrome? (P5.193). Neurology. 84(14_supplement).

Fraser, Christopher C., David H. Altreuter, Petr O. Ilyinskii, et al.. (2014). Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates. Vaccine. 32(24). 2896–2903. 58 indexed citations

Wingerchuk, Dean M., Mark Keegan, Elizabeth A. Shuster, et al.. (2014). Aspirin is Unlikely to Have A Clinically Meaningful Effect on Multiple Sclerosis-Related Fatigue: Data From a Randomized Controlled Trial (P7.245). Neurology. 82(10_supplement). 2 indexed citations

Wicklund, Meredith, Brendan Kelley, Bradley F. Boeve, et al.. (2013). Familial Dementia, Parkinsonism, Seizures and Spastic Paraparesis Associated with the Novel Y288H Presenilin-1 Mutation (PD5.008). Neurology. 80(7_supplement).

Pittet, Lynnelle A., David H. Altreuter, Petr O. Ilyinskii, et al.. (2012). Development and preclinical evaluation of SEL-068, a novel targeted Synthetic Vaccine Particle ( t SVP™) for smoking cessation and relapse prevention that generates high titers of antibodies against nicotine (75.11). The Journal of Immunology. 188(1_Supplement). 75.11–75.11. 12 indexed citations

Posthumus, Michael, Alison V. September, Mark Keegan, et al.. (2009). Genetic risk factors for anterior cruciate ligament ruptures: COL1A1 gene variant. British Journal of Sports Medicine. 43(5). 352–356. 150 indexed citations

Scarisbrick, Isobel A., Alexander G. Vandell, Mark Keegan, et al.. (2008). Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biological Chemistry. 389(6). 739–745. 62 indexed citations

Keegan, Mark, Fatima König, Robyn L. McClelland, et al.. (2005). Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. The Lancet. 366(9485). 579–582. 310 indexed citations

10.

Keegan, Mark, Alvaro A. Pineda, Robyn L. McClelland, et al.. (2002). Plasma exchange for severe attacks of CNS demyelination: Predictors of response. Neurology. 58(1). 143–146. 433 indexed citations

11.

Crowe, Simon F., Christine Doyle, J. F. Fielding, et al.. (1995). Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation. Gastroenterology. 108(4). A1054–A1054. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact